Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis
Clinical trial NCT00695643 · TERMINATED
Trial details
- NCT number
- NCT00695643
- Sponsor
- Dr. Falk Pharma GmbH
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2011-11-01
- Enrollment
- 345
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.